Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting biofilms using phages and their enzymes
Joana Azeredo, Pilar García, Zuzanna Drulis‐Kawa
Current Opinion in Biotechnology (2021) Vol. 68, pp. 251-261
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review
Muluneh Assefa, Azanaw Amare
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 5061-5068
Open Access | Times Cited: 105
Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review
Siyu Liu, Hongyun Lu, Shengliang Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 427-427
Open Access | Times Cited: 101
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
Aleksandra Petrović Fabijan, Jonathan R. Iredell, Katarzyna Danis‐Wlodarczyk, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002119-e3002119
Open Access | Times Cited: 64
Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on Quorum Sensing (QS) Signal-Response System and Innovative Non-Antibiotic Strategies for Their Elimination
Edyta Juszczuk‐Kubiak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2655-2655
Open Access | Times Cited: 23
Phage-antibiotic combinations to control Pseudomonas aeruginosa–Candida two-species biofilms
Prasanth Manohar, Belinda Loh, N. Ramesh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
Katarzyna Danis‐Wlodarczyk, Daniel J. Wozniak, Stephen T. Abedon
Antibiotics (2021) Vol. 10, Iss. 12, pp. 1497-1497
Open Access | Times Cited: 93
Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents
Stephen Amankwah, Kedir Abdella Abdusemed, Tesfaye Kassa
Nanotechnology Science and Applications (2021) Vol. Volume 14, pp. 161-177
Open Access | Times Cited: 74
Biological foundations of successful bacteriophage therapy
Carola Venturini, Aleksandra Petrović Fabijan, Alicia Fajardo Lubián, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 7
Open Access | Times Cited: 61
An Explorative Review on Advanced Approaches to Overcome Bacterial Resistance by Curbing Bacterial Biofilm Formation
F Mohamad, Raghad Alzahrani, Ahlam Alsaadi, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 19-49
Open Access | Times Cited: 37
Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies
Asghar Ali, Andaleeb Zahra, Mohan Kamthan, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1934-1934
Open Access | Times Cited: 34
New strategies and mechanisms for targeting Streptococcus mutans biofilm formation to prevent dental caries: A review
Zhen Gao, Xiaoyong Chen, Chen Wang, et al.
Microbiological Research (2023) Vol. 278, pp. 127526-127526
Closed Access | Times Cited: 31
Genetic engineering of bacteriophages: Key concepts, strategies, and applications
Wajid Hussain, Xiaohan Yang, Mati Ullah, et al.
Biotechnology Advances (2023) Vol. 64, pp. 108116-108116
Closed Access | Times Cited: 26
A multifunctional nanoplatform with “disruption and killing” function to improve the efficiency of conventional antibiotics for biofilm eradication
Dongxu Jia, Yi Zou, Jingjing Cheng, et al.
Journal of Material Science and Technology (2024) Vol. 205, pp. 98-108
Closed Access | Times Cited: 14
Nanocomposites against Pseudomonas aeruginosa biofilms: Recent advances, challenges, and future prospects
Basma A. Omran, Boo Shan Tseng, Kwang‐Hyun Baek
Microbiological Research (2024) Vol. 282, pp. 127656-127656
Closed Access | Times Cited: 13
Expression and characterization of a novel endolysin LysPFX32 as potential biological antimicrobial agent against Pseudomonas fluorescens for pork preservation
Peng Guan, Zixin Ming, Xi Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 139448-139448
Closed Access | Times Cited: 1
Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts
Ahmad Almatroudi
Biology (2025) Vol. 14, Iss. 2, pp. 165-165
Open Access | Times Cited: 1
Engineering bacteriophages for targeted superbug eradication
Ghazal Ghaznavi, Parisa Vosough, Abdolmajid Ghasemian, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
Stephen T. Abedon, Katarzyna Danis‐Wlodarczyk, Diana Alves
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1157-1157
Open Access | Times Cited: 48
Promising strategies to control persistent enemies: Some new technologies to combat biofilm in the food industry—A review
Senakpon Isaïe Ulrich Mevo, Md. Ashrafudoulla, Md. Furkanur Rahaman Mizan, et al.
Comprehensive Reviews in Food Science and Food Safety (2021) Vol. 20, Iss. 6, pp. 5938-5964
Closed Access | Times Cited: 47
A systematic review of the use of bacteriophages for in vitro biofilm control
Luciana Meneses, Ana Brandão, Tom Coenye, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 8, pp. 919-928
Open Access | Times Cited: 20
Beyond the Risk of Biofilms: An Up-and-Coming Battleground of Bacterial Life and Potential Antibiofilm Agents
Mohamed Zeineldin, Ahmed Esmael, Rashad R. Al-Hindi, et al.
Life (2023) Vol. 13, Iss. 2, pp. 503-503
Open Access | Times Cited: 16
Phage therapy for bone and joint infections: A comprehensive exploration of challenges, dynamics, and therapeutic prospects
Jiaze Peng, Caopei Guo, Chengbing Yang, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 39, pp. 12-21
Open Access | Times Cited: 5
A VersaTile Approach to Reprogram the Specificity of the R2-Type Tailocin Towards Different Serotypes of Escherichia coli and Klebsiella pneumoniae
Dorien Dams, Célia Pas, Agnieszka Łątka, et al.
Antibiotics (2025) Vol. 14, Iss. 1, pp. 104-104
Open Access
Structural characteristics, functions, and counteracting strategies of biofilms in Staphylococcus aureus
Yi-qi Xia, Zhenghui Hu, Qiyuan Jin, et al.
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 488-500
Open Access
Bacteriophage-Based Therapies in Oral Cancer: A New Frontier in Oncology
Vishnu Priya Panneerselvam, Leela Kagithakara Vajravelu, Rahul Harikumar Lathakumari, et al.
Cancer Pathogenesis and Therapy (2025)
Open Access
Page 1 - Next Page

Scroll to top